Skip to main content
SpringerLink
Log in

Alectinib/amiodarone

Hepatic cytolysis following intentional drug misuse and hypothyroidism: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Thomas QD, et al. Enteral administration of alectinib for ALK-positive non-small cell lung cancer in an elderly patient: A case report. Medicine 100: No. 43, 29 Oct 2021. Available from: URL: http://doi.org/10.1097/MD.0000000000027611

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alectinib/amiodarone. Reactions Weekly 1888, 23 (2022). https://doi.org/10.1007/s40278-022-08365-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-08365-7

Search

Navigation